Cambridge, MA, United States of America

Jennifer Downing

This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Boehringer Ingelheim International Gmbh, Recludix Pharma, Inc., Ribon Therapeutics, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Downing. Retrieved from https://idiyas.com/inventor/jennifer-downing-brknm8p0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Jennifer Downing

Introduction

Jennifer Downing is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. With a total of 5 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents, Jennifer has developed heterobicyclic amides as inhibitors of CD38. This invention relates to heterobicyclic amides and related compounds that serve as inhibitors of CD38, which are useful in the treatment of cancer. Her innovative approach in this area showcases her commitment to advancing medical science.

Career Highlights

Throughout her career, Jennifer has worked with notable companies such as Boehringer Ingelheim International GmbH and Ribon Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jennifer has collaborated with esteemed colleagues, including Laurie B. Schenkel and Kevin Wayne Kuntz. These partnerships have played a crucial role in her research and development efforts.

Conclusion

Jennifer Downing's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her innovative spirit and dedication to improving healthcare. Her patents and collaborations reflect her significant impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…